SEARCH

SEARCH BY CITATION

References

  • 1
    Preparing for induction of labour. In: EnkinM, KeirseMJ, NeilsonJ, CrowtherC, DulelyL, HodnettE, HofmeyrJ (editors). A Guide to Effective Care in Pregnancy and Childbirth, 3rd edn. Chapter 39. New York, NY: Oxford University Press; 2000. pp. 37582.
  • 2
    Prysak M, Castronova FC. Elective induction versus spontaneous labor: a case control analysis of safety and efficacy. Obstet Gynecol 1998;92:4752.
  • 3
    Zlatnik FJ. Elective induction of labor. Clin Obstet Gynecol 1999;42:75765.
  • 4
    Bishop EH. Elective induction of labor. Obstet Gynecol 1955;5:51027.
  • 5
    Bishop EH. Pelvic scoring for elective induction. Obstet Gynecol 1964;24:2668.
  • 6
    Olah KS, Gee H, Brown JS. Cervical contractions: the response of the cervix to oxytocic stimulation the latent phase of labor. Br J Obstet Gynaecol 1993;100:63540.
  • 7
    Liggins GC. Cervical ripening as an inflammatory reaction. In: EllwoodDA, AndersonABM, editors. The Cervix in Pregnancy and Labor, Clinical and Biochemical Investigations. Edinburgh: Churchill Livingstone; 1983. pp. 19.
  • 8
    Sanchez-Ramos L, Kaunitz AM, Del Valle GO, Delke I, Schroeder PA, Briones DK. Labor induction with prostaglandin E1 methyl analogue misoprostol versus oxytocin: a randomized trial. Obstet Gynecol 1993;332:815.
  • 9
    Garry D, Figuerosa R, Kalish RB, Catalano CJ, Maulik D. Randomized controlled trial of vaginal misoprostol versus dinoprostone vaginal insert for labor induction. J Matern Fetal Neonatal Med 2003;13:2549.
  • 10
    Agarwal N, Gupta A, Kriplani A, Bhatia N. Six hourly vaginal misoprostol versus intra-cervical dinoprostone for cervical ripening and labor induction. J Obstet Gynaecol Res 2003;29:14751.
  • 11
    Mackenzie IZ. The therapeutic roles of prostaglandin in obstetrics. In: StyddI (editor). Progress in Obstetrics and Gynecology, Vol. 8. Chapter 11. London: Churchill Livingstone; 1990. pp. 14973.
  • 12
    ACOG Committee Opinion. Number 283 May 2003. New U.S. Food and Drug Administration labeling of cytotec (misoprostol) use and pregnancy. Obstet Gynecol 2003;101:104950.
  • 13
    Alfirevic Z, Weeks A. Oral misoprostol for induction of labor. Cochrane Database Syst Rev 2006;CD001338.
  • 14
    Moodley J, Venkatachalam S, Songca P. Misoprostol for cervical ripening at and near term: a comparative study. S Afr Med J 2003;93:3714.
  • 15
    Lokugamage AU, Forsyth SF, Sullivan KR, El-Refaey H, Rodeck CH. Dinoprostone versus misoprostol: a randomized study of nulliparous women undergoing induction of labor. Acta Obstet Gynecol Scand 2003;82:1337.
  • 16
    Thomas A, Jophy R, Maskhar A, Thomas RK. Uterine rupture in a primigravida with misoprostol used for induction of labor. BJOG 2003;110:2178.
  • 17
    Phillip H, Fletcher H, Reid M. The impact of induced labour on postpartum blood loss. J Obstet Gynaecol 2004;24:1215.
  • 18
    National Institute of Clinical Excellence (NICE). Induction of labor: inherited clinical guideline D. 2000 [www.nice.org.uk/].
  • 19
    Pitchard JA, Baldwin RM, Dickey JC, Wiggins KM. Blood volume changes in pregnancy peurperium: II. Red blood cell loss and changes in apparent blood volume during and following vaginal delivery, caesarean section, plus total hysterectomy. Am J Obstet Gynecol 1962;84:127182.
  • 20
    American College of Obstetricians and Gynecologists. Post-partum Hemorrhage. ACOG Educational Bulletin Number 243:Washington, DC: ACOG, 1997.
  • 21
    Lye SJ. The initiation and inhibition of labor: toward a molecular understanding. Semin Reprod Endocrinol 1994;12:28494.
  • 22
    Coleman RA, Smith WL, Narumiya S VIII. International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev 1994;46:20529.
  • 23
    Senior J, Marshall K, Sangha R, Clayton JK. In-vitro characterization of prostanoid receptors on human myometrium at term pregnancy. Br J Pharmacol 1993;108:5016.
  • 24
    Meydanli MM, Caliskan E, Burak F, Narin MA, Atmaca R. Labor induction post-term with 25 microgram vs. 50 micrograms of intravaginal misoprostol. Int J Gynaecol Obstet 2003;81:24955.